Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience

Overview of attention for article published in Clinical Lung Cancer, May 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

guideline: 1 clinical guideline source

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 1 Guideline that references this research output.

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Clinical guideline published by National Comprehensive Cancer Network (NCCN) on 01 Dec 2021

The National Comprehensive Cancer Network (NCCN) is a non-profit alliance of 33 leading cancer centers focused on enhancing patient care, research, and education. It aims to improve cancer care quality and accessibility through comprehensive guidelines and resources for clinicians and patients.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.